Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6132355

CCOC(=O)c1ccc(-c2cn3nc(-c4ccc(N5CCN([C@H]6CC[C@@H](C)CC6)CC5)cc4)sc3n2)cc1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
GAA P10253 1/20 0.37
DPP4 P27487 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
TP53 P04637 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
CA9 Q16790 2/20 0.36
METAP1 P53582 1/20 0.36
ALDH1A1 P00352 1/20 0.36
POLB P06746 1/20 0.36
RARA P10276 1/20 0.35
RARB P10826 1/20 0.35
RARG P13631 1/20 0.35
LMNA P02545 1/20 0.35
THRB P10828 1/20 0.35
ADORA3 P0DMS8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7320929 0.93 ALDH1A1 (0.42) MAPTGAADPP4DPP7TP53
Trifluoroacetic Acid SCHEMBL6132991 0.88 ALDH1A1 (0.39) MAPTGAADPP4DPP7TP53
Trifluoroacetic Acid SCHEMBL7317609 0.87 TP53 (0.41) MAPTTP53CA12CA1CA2
Trifluoroacetic Acid SCHEMBL7325659 0.87 SIRT2 (0.46) MAPTGAATP53CA12CA1
Trifluoroacetic Acid SCHEMBL7324043 0.86 MTOR (0.42) MAPTTP53CA12CA1CA2
Trifluoroacetic Acid SCHEMBL7323148 0.86 LMNA (0.48) MAPTTP53CA12CA1CA2
Trifluoroacetic Acid SCHEMBL6132999 0.84 SIRT2 (0.40) MAPTGAADPP4DPP7TP53
Hydrochloric Acid SCHEMBL6132504 0.84 USP2 (0.45) MAPTTP53CA12CA1CA2
Hydrochloric Acid SCHEMBL6132508 0.84 USP2 (0.45) MAPTTP53CA12CA1CA2
Trifluoroacetic Acid SCHEMBL6132482 0.83 POLB (0.40) MAPTGAADPP4DPP7TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884774-B2 Cyclic hexapeptide derivatives FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-04-26 US disclosed
EP-1259535-B1 CYCLIC HEXAPEPTIDE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2005-04-13 EP disclosed
US-20030083238-A1 Cyclic hexapeptide derivatives ASTELLAS PHARMA INC. (JP) 2003-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030083238-A1 Cyclic hexapeptide derivatives NGLY1, ALG1, CHIT1 MAPT 3424/4885GAA 247/4885DPP4 1059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.